Hydroxychloroquine, TTP, COVID-19, and SLE.
作者信息
Sookaromdee Pathum, Wiwanitkit Viroj
机构信息
Private Academic Consultant, Bangkok, Thailand
Adjunct Professor, Joseph Ayobabalola University, Ikeji-Arakeji, Nigeria
出版信息
Turk J Haematol. 2021 Feb 25;38(1):99-100. doi: 10.4274/tjh.galenos.2021.2020.0770. Epub 2021 Jan 6.
Abstract
摘要
相似文献
1
Hydroxychloroquine, TTP, COVID-19, and SLE.羟氯喹、血栓性血小板减少性紫癜、2019冠状病毒病和系统性红斑狼疮。
Turk J Haematol. 2021 Feb 25;38(1):99-100. doi: 10.4274/tjh.galenos.2021.2020.0770. Epub 2021 Jan 6.
2
Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.2019年冠状病毒病大流行期间系统性红斑狼疮患者的羟氯喹短缺情况：系统性红斑狼疮国际协作诊所的经验
Ann Rheum Dis. 2021 Feb;80(2):1-2. doi: 10.1136/annrheumdis-2020-218164. Epub 2020 Jun 25.
3
Immune Thrombotic Thrombocytopenic Purpura in a Patient with Suspected COVID-19: Hydroxychloroquine Culprit or Just Happenstance?一名疑似新冠肺炎患者的免疫性血栓性血小板减少性紫癜：羟氯喹是罪魁祸首还是纯属巧合？
Turk J Haematol. 2021 Jun 1;38(2):155-157. doi: 10.4274/tjh.galenos.2021.2021.0057. Epub 2021 Feb 5.
4
Immune-mediated thrombotic thrombocytopenic purpura in patients with and without systemic lupus erythematosus: a retrospective study.免疫介导的血栓性血小板减少性紫癜患者伴或不伴系统性红斑狼疮：一项回顾性研究。
Orphanet J Rare Dis. 2020 Aug 28;15(1):225. doi: 10.1186/s13023-020-01510-9.
5
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.COVID-19 患者伴系统性红斑狼疮，SARS-CoV-2 RNA 阳性复发后成功康复：病例报告及文献复习。
Clin Rheumatol. 2020 Sep;39(9):2803-2810. doi: 10.1007/s10067-020-05230-0. Epub 2020 Jul 28.
6
Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab.成功治疗系统性红斑狼疮相关难治性血栓性血小板减少性紫癜：联合应用血浆置换和低剂量利妥昔单抗。
Lupus. 2020 Dec;29(14):1961-1967. doi: 10.1177/0961203320953473. Epub 2020 Aug 24.
7
Acquired thrombotic thrombocytopenic purpura: puzzles, curiosities and conundrums.获得性血栓性血小板减少性紫癜：谜题、奇事和难题。
J Thromb Thrombolysis. 2011 Jan;31(1):119-21. doi: 10.1007/s11239-010-0517-x.
8
Risk factors and clinical profile of thrombotic thrombocytopenic purpura in systemic lupus erythematosus patients. Is this a distinctive clinical entity in the thrombotic microangiopathy spectrum?: a case control study.系统性红斑狼疮患者血栓性血小板减少性紫癜的危险因素及临床特征。这是血栓性微血管病谱中的一种独特临床实体吗？：一项病例对照研究。
Thromb Res. 2014 Nov;134(5):1020-7. doi: 10.1016/j.thromres.2014.09.005. Epub 2014 Sep 16.
9
Response to belimumab in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a case-based review.对与系统性红斑狼疮相关的血栓性血小板减少性紫癜中使用贝利尤单抗的反应：基于病例的综述。
Clin Rheumatol. 2022 Aug;41(8):2561-2569. doi: 10.1007/s10067-022-06155-6. Epub 2022 May 7.
10
Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus.系统性红斑狼疮背景下血栓性血小板减少性紫癜的综述
Semin Arthritis Rheum. 1998 Aug;28(1):1-19. doi: 10.1016/s0049-0172(98)80023-1.
引用本文的文献
1
Incidence of COVID-19 Hospitalisation in Patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study from Denmark.系统性红斑狼疮患者新冠病毒肺炎住院率：丹麦全国队列研究
J Clin Med. 2021 Aug 27;10(17):3842. doi: 10.3390/jcm10173842.
2
Immune Thrombotic Thrombocytopenic Purpura in a Patient with Suspected COVID-19: Hydroxychloroquine Culprit or Just Happenstance?一名疑似新冠肺炎患者的免疫性血栓性血小板减少性紫癜：羟氯喹是罪魁祸首还是纯属巧合？
Turk J Haematol. 2021 Jun 1;38(2):155-157. doi: 10.4274/tjh.galenos.2021.2021.0057. Epub 2021 Feb 5.
本文引用的文献
1
COVID-19 presenting as thrombotic thrombocytopenic purpura (TTP).新冠病毒感染表现为血栓性血小板减少性紫癜（TTP）。
BMJ Case Rep. 2020 Dec 17;13(12):e238026. doi: 10.1136/bcr-2020-238026.
2
False-negative results of initial RT-PCR assays for COVID-19: A systematic review.COVID-19 初始 RT-PCR 检测的假阴性结果：系统评价。
PLoS One. 2020 Dec 10;15(12):e0242958. doi: 10.1371/journal.pone.0242958. eCollection 2020.
3
Routine blood analysis greatly reduces the false-negative rate of RT-PCR testing for Covid-19.常规血液分析大大降低了新冠病毒RT-PCR检测的假阴性率。
Acta Biomed. 2020 Sep 7;91(3):e2020003. doi: 10.23750/abm.v91i3.9843.
4
Hydroxychloroquine-Associated Thrombotic Thrombocytopenic Purpura.羟氯喹相关血栓性血小板减少性紫癜
Turk J Haematol. 2020 Nov 19;37(4):302-304. doi: 10.4274/tjh.galenos.2020.2020.0322. Epub 2020 Jul 23.
5
Cardiac implications of thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的心脏影响
World J Cardiol. 2018 Dec 26;10(12):254-266. doi: 10.4330/wjc.v10.i12.254.
6
Thrombotic thrombocytopenic purpura as the first presentation in systemic lupus erythematosus.血栓性血小板减少性紫癜作为系统性红斑狼疮的首发表现。
Reumatologia. 2018;56(4):268-270. doi: 10.5114/reum.2018.77980. Epub 2018 Aug 31.
7
First symptoms in patients with thrombotic thrombocytopenic purpura: what are they and when do they occur?血栓性血小板减少性紫癜患者的首发症状：有哪些首发症状以及何时出现？
Transfusion. 2013 Jan;53(1):235-7. doi: 10.1111/j.1537-2995.2012.03934.x.
Zotero 插件